Dyadic raises $2.9M for working capital
In Florida, biotech company Dyadic International has entered into definitive agreements with an institutional investor to raise approximately $2.9 million through a registered direct offering of common stock and a concurrent private placement of warrants. The company will use the funds for general corporate purposes and working capital. The offering price per share of Common […]
